Article Versions Notes

Shen DH-Y, Chan H-P, Tsai F-R, Hu C, Chen AY-N, Chan H-Y, Lee C-H, Chuang K-P, Yang M-H, Tyan Y-C. Prognostic Value of ¹⁸F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Node-Negative Stage II Esophageal Squamous Cell Carcinoma. Metabolites. 2022; 12(1):7. https://doi.org/10.3390/metabo12010007

Shen, Daniel Hueng-Yuan, Hung-Pin Chan, Fu-Ren Tsai, Chin Hu, Allan Yi-Nan Chen, Hung-Yen Chan, Che-Hsin Lee, Kuo-Pin Chuang, Ming-Hui Yang, and Yu-Chang Tyan. 2022. "Prognostic Value of ¹⁸F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Node-Negative Stage II Esophageal Squamous Cell Carcinoma" Metabolites 12, no. 1: 7. https://doi.org/10.3390/metabo12010007

Shen, D. H.-Y., Chan, H.-P., Tsai, F.-R., Hu, C., Chen, A. Y.-N., Chan, H.-Y., Lee, C.-H., Chuang, K.-P., Yang, M.-H., & Tyan, Y.-C. (2022). Prognostic Value of ¹⁸F-FDG PET/CT Volume-Based Metabolic Parameters in Patients with Node-Negative Stage II Esophageal Squamous Cell Carcinoma. Metabolites, 12(1), 7. https://doi.org/10.3390/metabo12010007